CDSCO asks state drug regulators to ‘keep a strong vigil’ on buclizine sales

Central Drugs Standard Control Organisation (CDSCO) has issued an advisory to state drug regulators.It has asked them to keep monitoring on the manufacture,sale and distribution of buclizine.It is a brand of antihistamine and used as a motion sickness medicine. This advisory came after it was found that a government order prohibiting the sale of buclizine… Continue reading CDSCO asks state drug regulators to ‘keep a strong vigil’ on buclizine sales